These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15860997)

  • 21. [Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study].
    Goday A; Gabriel R; Ascaso JF; Franch J; Ortega R; Martínez O; Lerones N;
    Rev Clin Esp; 2008 Sep; 208(8):377-85. PubMed ID: 18817695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Al Rifai M; Silverman MG; Nasir K; Budoff MJ; Blankstein R; Szklo M; Katz R; Blumenthal RS; Blaha MJ
    Atherosclerosis; 2015 Apr; 239(2):629-33. PubMed ID: 25683387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Using the combination of traditional risk factors and quantitative coronary angiography (QCA) in predicting the risk of individuals with subclinical artherosclerosis].
    Wang GZ; Lv SZ; Liu JH; Chen YD; Huo Y; Gao W; Wang WM; Chen F; Zhou YJ; Li ZZ; Ke YN; Yang XC; Zhang SY; Yan HB; Li HW; Shi DZ; Chen BX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1383-8. PubMed ID: 21223669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome.
    Jahangiry L; Farhangi MA; Rezaei F
    J Health Popul Nutr; 2017 Nov; 36(1):36. PubMed ID: 29132438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk associated with the metabolic syndrome.
    Lindsay RS; Howard BV
    Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes.
    Birhan Yilmaz M; Guray U; Guray Y; Altay H; Demirkan B; Caldir V; Cay S; Refiker ME; Sasmaz H; Korkmaz S
    Coron Artery Dis; 2005 Aug; 16(5):287-92. PubMed ID: 16000886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased detection of coronary atherosclerosis on 320-slice computed tomographic angiography with burden of cardiovascular risk factors and complications in patients with type 2 diabetes.
    Rong J; Bai SR; Chen YL; He C
    J Diabetes Complications; 2016 Apr; 30(3):494-500. PubMed ID: 26823230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis.
    Uthoff H; Staub D; Socrates T; Meyerhans A; Bundi B; Schmid HP; Frauchiger B
    Vasa; 2010 Nov; 39(4):325-33. PubMed ID: 21104622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical derivation to improve the definition of the metabolic syndrome in the evaluation of cardiovascular disease risk.
    Wildman RP; McGinn AP; Kim M; Muntner P; Wang D; Cohen HW; Ogorodnikova AD; Reynolds K; Fonseca V
    Diabetes Care; 2011 Mar; 34(3):746-8. PubMed ID: 21285391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review.
    Peters SA; den Ruijter HM; Bots ML; Moons KG
    Heart; 2012 Feb; 98(3):177-84. PubMed ID: 22095617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.
    Cohen JB; Cohen DL
    Curr Hypertens Rep; 2015 May; 17(5):34. PubMed ID: 25833456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis.
    Gepner AD; Young R; Delaney JA; Budoff MJ; Polak JF; Blaha MJ; Post WS; Michos ED; Kaufman J; Stein JH
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28196817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of cardiovascular risk factors on subclinical left main coronary artery disease: an intravascular ultrasound study.
    Kim SW; Mintz GS; Escolar E; Ohlmann P; Pregowski J; Tyczynski P; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
    Am Heart J; 2006 Oct; 152(4):693.e7-12. PubMed ID: 16996839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Stratification for Cardiovascular Disease in Women in the Primary Care Setting.
    Roy RR; Hurst RT; Lester SJ; Kendall C; Baxter C; Wu Q; Borovansky J; Files J; Panse P; Wilansky S
    J Am Soc Echocardiogr; 2015 Oct; 28(10):1232-9. PubMed ID: 26243701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular consequences of metabolic syndrome.
    Tune JD; Goodwill AG; Sassoon DJ; Mather KJ
    Transl Res; 2017 May; 183():57-70. PubMed ID: 28130064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
    Stern MP; Williams K; González-Villalpando C; Hunt KJ; Haffner SM
    Diabetes Care; 2004 Nov; 27(11):2676-81. PubMed ID: 15505004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.
    Osborne MT; Bajaj NS; Taqueti VR; Gupta A; Bravo PE; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
    J Am Coll Cardiol; 2017 Dec; 70(22):2835-2837. PubMed ID: 29191335
    [No Abstract]   [Full Text] [Related]  

  • 39. Association of biomarkers with atherosclerosis and risk for coronary artery disease in patients with HIV.
    Falcão Mda C; Zírpoli JC; Albuquerque VM; Markman Filho B; Araújo NA; Falcão CA; Miranda-Filho Dde B; Ximenes RA; Albuquerque Mde F; Lacerda HR
    Arq Bras Cardiol; 2012 Nov; 99(5):971-8. PubMed ID: 23080223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.